Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Influence of Obstructive Sleep Apnea on Soluble Intercellular Adhesion Molecule-1 and Vascular Endothelial Growth Factor

폐쇄성 수면 무호흡이 Soluble Intercellular Adhesion Molecule-1과 Vascular Endothelial Growth Factor에 미치는 영향

  • Kim, Jeong Pyo (Department of Internal Medicine, The Catholic University of Korea, College of Medicine) ;
  • Lee, Sang Haak (Department of Internal Medicine, The Catholic University of Korea, College of Medicine) ;
  • Kwon, Soon Seog (Department of Internal Medicine, The Catholic University of Korea, College of Medicine) ;
  • Kim, Young Kyun (Department of Internal Medicine, The Catholic University of Korea, College of Medicine) ;
  • Kim, Kwan Hyoung (Department of Internal Medicine, The Catholic University of Korea, College of Medicine) ;
  • Song, Jeong Sup (Department of Internal Medicine, The Catholic University of Korea, College of Medicine) ;
  • Park, Sung Hak (Department of Internal Medicine, The Catholic University of Korea, College of Medicine) ;
  • Moon, Hwa Sik (Department of Internal Medicine, The Catholic University of Korea, College of Medicine)
  • 김정표 (가톨릭대학교 의과대학 내과학교실) ;
  • 이상학 (가톨릭대학교 의과대학 내과학교실) ;
  • 권순석 (가톨릭대학교 의과대학 내과학교실) ;
  • 김영균 (가톨릭대학교 의과대학 내과학교실) ;
  • 김관형 (가톨릭대학교 의과대학 내과학교실) ;
  • 송정섭 (가톨릭대학교 의과대학 내과학교실) ;
  • 박성학 (가톨릭대학교 의과대학 내과학교실) ;
  • 문화식 (가톨릭대학교 의과대학 내과학교실)
  • Published : 2004.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background : Obstructive sleep apnea is a contributory factor of hypertension, arrhythmia, ischemic heart disease and other cardiovascular diseases. However, the pathophysiology underlying this relationship is unclear. Recent reports have shown that the soluble intercellular adhesion molecule-1(sICAM-1) and vascular endothelial growth factor(VEGF) are involved in the initiation and progression of atherosclerosis, and some reports state that increased levels of these cytokines are found in patients with obstructive sleep apnea. In this study, the levels of sICAM-1 and VEGF were measured in patients with obstructive sleep apnea in order to determine if obstructive sleep apnea is involved in the pathophysiology of cardiovascular diseases. Methods : Thirty-seven patients were chosen amongst a population who visited the Sleep Disorders Clinic of St. Paul's Hospital in Seoul, Korea for a diagnosis of obstructive sleep apnea and who had subsequently undergone an overnight polysomnography at the clinic. The sera from these patients were retrieved after an overnight polysomnography session and the samples were kept at $-70^{\circ}C$. The cytokine levels were determined with ELISA and the relationships between the serum levels of sICAM-1 and VEGF along with polysomnography parameters were analyzed. Results : No statistically significant correlation was observed between the sICAM-1 levels and the apnea-hypopnea index(r=0.27, P>0.05). Positive correlations were found between the apnea-hypopnea index and serum VEGF levels (r=0.50, P<0.01), the apnea index and the serum sICAM-1 levels (r=0.31, P<0.01), and the apnea index and the serum VEGF levels (r=0.45, P<0.01). Conclusions : Obstructive apnea or hypopnea leads to an increase in the sICAM-1 and VEGF levels. Such an increase in the cytokine levels most likely leads to the higher incidence of cardiovascular diseases observed in patients with obstructive sleep apnea.

연구배경 : 폐쇄성 수면 무호흡 증후군은 고혈압과 심부정맥 및 허혈성 심질환 등의 심혈관질환을 일으키는 위험요소로 알려져 있으나 정확한 기전에 대해서는 아직 확실히 밝혀져 있지 않다. 최근에 soluble intercellular adhesion molecule-1(sICAM-1)과 vascular endothelial growth factor(VEGF)가 죽상경화증의 발생과 진행에 관여한다고 알려지면서, 일부 연구에서는 이러한 사이토카인이 폐쇄성 수면 무호흡 증후군에서도 증가한다고 보고하였다. 저자는 폐쇄성 수면 무호흡 증후군 환자에서 sICAM-1과 VEGF의 농도 변화를 관찰함으로써, 이들 환자에서 동반될 수 있는 심혈관질환 발생의 병태생리를 일부 이해하고자 하였다. 방 법 : 폐쇄성 수면 무호흡 증후군을 진단하기 위해 가톨릭대학교 성바오로병원 수면장애크리닉을 방문하여 수면다원검사를 시행한 37명을 대상으로 하였다. 철야 수면다원검사를 종료한 직후 혈액 채취를 한 후 혈청분리를 하여 $-70^{\circ}C$ 냉장고에 보관하였다. 사이토카인의 측정은 ELISA 방법으로 시행하였고 수면다원검사의 각 지표와 혈청 sICAM-1 농도 및 혈청 VEGF 농도와의 상관 관계를 비교 분석하였다. 결 과 : 무호흡-저호흡지수와 혈청 sICAM-1 농도 사이에는 유의한 상관관계가 없었지만(r=0.27, P>0.05), 무호흡-저호흡지수와 혈청 VEGF 농도는 유의한 상관관계가 있었다(r=0.50, P<0.01). 무호흡지수와 혈청 sICAM-1 농도는 다소 유의한 상관관계가 있었으며(r=0.31, P<0.01) 무호흡지수와 혈청 VEGF 농도 사이에는 유의한 상관관계가 있었다(r=0.45, P<0.01). 결 론 : 폐쇄성 수면 무호흡 혹은 저호흡은 혈청내 sICAM-1 및 VEGF 농도를 증가시키는 것을 알 수 있었으며, 이러한 사이토카인의 발현 증가는 폐쇄성 수면무호흡 증군 환자에서 심혈관질환의 발생에 관련이 있을 것으로 추측된다.

Keywords

References

  1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5
  2. Roux F, D'Ambrosio C, Mohsenin V. Sleeprelated breathing disorders and cardiovascular disease. Am J Med 2000;108:396-402
  3. Weiss JW, Launois SH, Anand A, Garpestad E. Cardiovasc morbidity in obstructive sleep apnea. Prog Cardiovascular Dis 1999;41:367-76
  4. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001;164:2147-65
  5. Frenette PS, Wagner DD. Adhesion mole-cules-first of two parts. N Engl J Med 1996;334:1526-9
  6. Price DT, Loscalzo J. Cellular adhesion mole-cules and atherogenesis. Am J Med 1999;107:85-97
  7. Hansson GK. Immune mechanisms in athero sclerosis. Arterioscler Thromb Vasc Biol 2001;21:1876-90
  8. Morisaki N, Saito I, Tamura K, Tashiro J, Masuda M, Kanzaki T, et al. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1(ICAM-1) and soluble vas cular cell adhesion molecule-1(VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis 1997;131:43-8
  9. Becker A, van Hinsberg VW, Jager A, Kostense PJ, Dekker JM, Nijpels G, et al.Why is soulble intercellular adhesion mole cule-1 related to cardiovascular mortality? Eur J Clin Invest 2002;32:1-8
  10. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic Implications. Semin Oncol 2002;29:10-4.
  11. Jain RK. Tumor angiogenesis and accessi bility: Role of vascular endothelial growth factor. Semin Oncol 2002;29:3-9
  12. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999;100:547-52
  13. Celletti FL, Waugh JM, Ambile PG, Bren-dolan A, Hilfiker PR, Dake MD. Vascularendothelial growth factor enhances athero sclerotic plaque progression. Nat Med 2001;7:425-9
  14. Zhao Q, Egashira K, Inoue S, Usui M, Kitamoto S, Ni W, et al. Vascular endothelial growth factor is necessary in the devel opment of arteriosclerosis by recruiting/ activating monocytes in a rat model of long-term inhibition of nitric oxide synthes is.Circulaton 2002;105:1110-5
  15. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syn drome. J Appl physiol 1999;87:10-4
  16. Imagawa S, Yamaguchi Y, Higuchi M, Neichi T, Hasegawa Y, Mukai HY, et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 2001;98:1255-7.
  17. Gozal D, Lipton AJ, Jones KL. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 2002;25: 59-65
  18. Lavie L, Kraiczi H, Hefetz A, Ghandour H, Perelman A, Hedner J, et al. Plasma vascular endothelial growth factor (VEGF) in sleep apnea syndrome: effects of nCPAP treatment. Am J Respir Crit Care Med 2002;165:1624-8
  19. Rechtschaffen A, Kales A. A manual of standarized terminology, techniques and sco-ring system for sleep stages of human subjects. Los Angeles, Brain information service/brain research institute, University of California Los Angeles 1968
  20. Partinen M, Telakivi T. Epidemiology of obstructive sleep apnea syndrome. Sleep 1992;15:S1-4
  21. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstru-ctive sleep apnea. Experience in 385 male patients. Chest 1988;94:9-14
  22. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortaltiy Chest 1988;94:1200-4
  23. 문화식, 노대근, 최영미, 김영균, 김관형, 송정섭, 박성학. 전신성 고혈압을 동반한 폐쇄성 수면 무호흡증후군 환자에서 각성시와 수면중의 혈장 Catecholamines 농도변화. 결핵 및 호흡기 질환 1996;43:600-12
  24. Cohen MC, Rohtla KM, Lavery CE, Muller JE, Mittleman MA. Meta-analysis of the morning excess of acute myocardial infar-ction and sudden cardiac death. Am J Car-diol 1997;79:1512-6
  25. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26
  26. Rader DJ. Inflammatory markers of coronary risk. N Engl J Med 2000; 343:1179-82
  27. El-Solh A, Mador MJ, Sikka P, Dhillon RS, Amsterdam D, Grant BJ. Adhesion molecule in patients with coronary artery disease and moderate-to severe obstructive sleep apnea. chest 2002;121:1541-7
  28. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 2003;7:35-51
  29. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma:tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-54
  30. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, et al. Overlapping patterns of activation of humanendothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986;137:1893-6.
  31. Weber C, Lu CF, Casanovas JM, Springer TA. Role of alpha L beta2 integrin avidity in transendothelial chemotaxis of mononuclear cells. J Immunol 1997;159:3968-75
  32. Porsch-Oezcueruemez M, Kunz D, Kloer HU,Luley C. Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease. J Am Coll Cardiol 1999;34:1995-2001
  33. Jaakkola K, Jalkanen S, Kaunismaki K, Vanttien E, Saukko P, Alanen K, et al.Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. J Am Coll Cardiol 2000;36:122-9
  34. Roy J, Audette M, Tremblay MJ. Inter-cellular adhesion molecule-1 (ICAM-1) gene expression in human T cells is regulated by phosphotyrosyl phosphatase activity. Involve ment of $NF-_{k}B$, Ets, and palindromic inter-feron-γ-responsive element-binding sites J Biol Chem 2001;276:14553-61
  35. Fan J, Frey RS, Rahman A, Malik AB. Role of neutrophil NADPH oxidase in the me-chanism of tumor necrosis factor-αinduced NF-κB activation and intercellular adhesion molecule-1 expression in endothelial cells. JBiol Chem 2002;277:3404-11
  36. Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M, et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 2000;109:562-7
  37. Shepard JW Jr. Gas exchange and hemo dynamics during sleep. Med Clin North Am 1985;69:1243-64
  38. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002;165: 934-9
  39. Shepard JW Jr. Cardiopulmonary conse quences of obstructive sleep apnea. Mayo Clin Proc 1990;65:1250-9
  40. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue?-G. H. A. Clowes memorial award lecture. Can cer Res 1986;46:467-73
  41. Fidler IJ, Ellis LM. The implications of angiogenesis for biology and therapy of cancer metastasis. Cell 1994;79:185-8
  42. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-72
  43. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, et al. Vascular perme ability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990;172:1535-45
  44. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the receptor Flt-1. Blood 1996; 87:3336-43.
  45. Marumo T, Schini-Kerth VB, Busse R. Vas cular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999;48:1131-7
  46. Dulak J, Jozkowicz A, Frick M, Alber HF, Dichtl W, Schwarzacher SP, et al. Vascular endothelial growth factor: angiogenesis, atherogenesis or both? J Am Coll Cardiol 2001;38:2137-8
  47. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 2002;165:67-70
  48. Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular disease: final report on 128 patients. Sleep 1999;22:217-23